Could Acadia use the p1 results from Neuren for Fragike X though - it would make sense from a safety perspective, but if that was the case then Neuren wouldn’t need to run any additional p1 trials fir the 3 additional indications they are running now, unless the dosage is different, but I don’t think it is…
Could Acadia use the p1 results from Neuren for Fragike X though...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.30 |
Change
0.760(4.59%) |
Mkt cap ! $2.211B | |||
| Open | High | Low | Value | Volume |
| $17.35 | $17.94 | $17.25 | $17.64M | 1.010M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 2533 | $17.30 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.45 | 1254 | 1 |
View Market Depth
| Last trade - 16.10pm 14/11/2024 (20 minute delay) ? |
| NEU (ASX) Chart |